Expansion of leadership team ensures continued evolution of leading patient portal
CARY, N.C. — November 5, 2013 — Medfusion, a leading provider of patient engagement and practice efficiency software, announced today the return of Vikram “Vik” Natarajan to the company as the new chief technology officer (CTO). The addition of Natarajan enables Medfusion to continue to expand product offerings and focus on innovation to better meet the demands of the continuously growing market. The hiring also comes on the heels of Medfusion unveiling its new brand and board members.
Natarajan brings over a decade of experience developing consumer-facing healthcare software and service solutions, including previously working for Medfusion as the lead architect of the core product. His experience with the portal structure from its beginning will allow the team to seamlessly upgrade and enhance the current patient portal to address patient and provider needs in the changing healthcare climate.
“Rejoining the Medfusion team provides a unique opportunity to change the way patients view their health information,” said Natarajan. “I’m excited to begin helping to enhance the platform on which Medfusion was originally built, increasing patient satisfaction and better serving the needs of our client base today and for the future.”
The Medfusion patient portal was designed to allow patients and providers alike to reliably access and share healthcare information. Patients using the technology can easily request appointments, pay bills, review health records and lab results, and communicate with their physicians in a convenient and secure manner.
“When we began this company 13 years ago, we set out to build a solution that would help change and improve the relationship between patients sand providers,” said Steve Malik, CEO and Chairman of Medfusion. “We are excited to welcome Vik back to the team to help us ensure that our solution remains top-notch, user-friendly, dependable, leading-edge and is a technology our users enjoy using regularly.”